[Federal Register Volume 84, Number 169 (Friday, August 30, 2019)]
[Notices]
[Pages 45766-45767]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18744]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2019-0073]
Advisory Committee on Immunization Practices (ACIP); Notice of
Meeting and Request for Comment
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), announces the
following meeting of the Advisory Committee on Immunization Practices
(ACIP). This meeting is open to the public, limited only by room
seating. The meeting room accommodates 216 for public seating. Room
245, adjacent to the meeting room, will be available once the meeting
room reaches capacity, providing up to 18 additional seats. Time will
be available for public comment. The meeting will be webcast live via
the World Wide Web; for meeting registration and more information on
ACIP please visit the ACIP website: http://www.cdc.gov/vaccines/acip/index.html.
DATES: The meeting will be held on October 23, 2019 8:00 a.m. to 5:00
p.m., EDT, and October 24, 2019 8:00 a.m. to 2:30 p.m. EDT.
Written comments must be received on or before October 28, 2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0073 by any of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Centers for Disease Control and Prevention, 1600
Clifton Road NE, MS A-27, Atlanta, GA 30329-4027, Attn: October ACIP
Meeting
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the https://www.regulations.gov suitability policy will be posted
without change to https://www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
Written public comments submitted by 72 hours prior to the ACIP meeting
will be provided to ACIP members before the meeting.
Meeting Location: Centers for Disease Control and Prevention, 1600
Clifton Road NE, Tom Harkin Global Communications Center, Building 19,
Kent `Oz' Nelson Auditorium, Atlanta, Georgia, 30329-4027.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, Centers for Disease Control and Prevention,
National Center for Immunization and Respiratory Diseases, 1600 Clifton
Road NE Atlanta, GA 30329-4027; Telephone: 404-639-8367; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged with advising the Director, CDC,
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s,
the committee is mandated to establish and periodically review and, as
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program,
along with schedules regarding dosing interval, dosage, and
contraindications to administration of vaccines. Further, under
provisions of the Affordable Care Act, section 2713 of the Public
Health Service Act, immunization recommendations of the ACIP that have
been approved by the Director of the Centers for Disease Control and
Prevention and appear on CDC immunization schedules must be covered by
applicable health plans.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on https://www.regulations.gov.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or
[[Page 45767]]
proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted in to the docket.
Oral Public Comment: This meeting will include time for members of
the public to make an in-person oral comment. Oral public comment will
occur before any scheduled votes including all votes relevant to the
ACIP's Affordable Care Act and Vaccines for Children Program roles.
Priority will be given to individuals who submit a request to make an
oral public comment before the meeting according to the procedures
below. On-site, in-person registration for oral public comment at the
meeting will only be available if there is time remaining in the oral
public comment session after all individuals who submitted a request to
make an oral comment before the meeting have had an opportunity to
speak. There is no guarantee there will be an opportunity for on-site,
in-person registration for oral public comment, and all individuals
interested in requesting to make an oral public comment are strongly
encouraged to submit a request according to the instructions below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the October ACIP meeting must submit a
request at http://www.cdc.gov/vaccines/acip/meetings/ no later than
11:59 p.m., EDT, October 9, 2019 according to the instructions
provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
lottery to determine the speakers for each scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email by October 16, 2019. To accommodate the significant
interest in participation in the oral public comment session of ACIP
meetings, each speaker will be limited to 3 minutes, and each speaker
may only speak once per meeting.
Written Public Comment: Written comments must be received on or
before October 28, 2019.
Matters to be Considered: The agenda will include discussions on
pertussis vaccines, child/adolescent immunization schedule, adult
immunization schedule, influenza vaccines, general best practices,
dengue vaccine, rabies vaccine, and herpes zoster vaccine. A
recommendation vote is scheduled for pertussis vaccines, child/
adolescent immunization schedule, and adult immunization schedule. A
Vaccines for Children recommendation vote is scheduled for pertussis
vaccines. Agenda items are subject to change as priorities dictate. For
more information on the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-18744 Filed 8-29-19; 8:45 am]
BILLING CODE 4163-18-P